Case docket: Novartis Pharmaceuticals Corporation et al v. Dr. Reddy's Laboratories, Ltd. et al

Case details

Court:	nysd
Docket #:	1:04-cv-06045
Case Name:	Novartis Pharmaceuticals Corporation et al v. Dr. Reddy's Laboratories, Ltd. et al
PACER case #:	252766
Date filed:	2004-08-04
Date terminated:	2008-02-29
Assigned to:	Judge Harold Baer
Referred to:	Magistrate Judge James C. Francis
Case Cause:	35:271 Patent Infringement
Nature of Suit:	830 Patent
Jury Demand:	None
Jurisdiction:	Federal Question

Parties

Represented Party	Attorney & Contact Info
Novartis Pharmaceuticals Corporation Plaintiff	Gregory B. Sephton Fitzpatrick, Cella, Harper & Scinto 30 Rockefeller Plaza New York, NY 10112 (212) 218-2100 LEAD ATTORNEY ATTORNEY TO BE NOTICED Nicholas Nicholas Kallas Fitzpatrick, Cella, Harper & Scinto 30 Rockefeller Plaza New York, NY 10112 212-218-2243 Fax: 212-218-2200 Email: nkallas@fchs.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Robert Louis Baechtold Fitzpatrick, Cella, Harper & Scinto(NYC) 1290 Avenue of the Americas New York, NY 10104-3800 212 218-2213 Fax: 212 218-2200 Email: rbaechtold@fchs.com LEAD ATTORNEY ATTORNEY TO BE NOTICED David M Conca Paul, Hastings, Janofsky & Walker LLP (NYC) 75 East 55th Street New York, NY 10022 212-318-6406 Fax: 212-230-7885 Email: davidconca@paulhastings.com TERMINATED: 10/30/2006
Novartis AG Plaintiff	Gregory B. Sephton (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Nicholas Nicholas Kallas (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Robert Louis Baechtold (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED David M Conca (See above for address) TERMINATED: 10/30/2006
Novartis Pharma AG Plaintiff	Gregory B. Sephton (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Nicholas Nicholas Kallas (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Robert Louis Baechtold (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED David M Conca (See above for address) TERMINATED: 10/30/2006
Novartis International Pharmaceutical Ltd. Plaintiff	Gregory B. Sephton (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Nicholas Nicholas Kallas (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Robert Louis Baechtold (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED David M Conca (See above for address) TERMINATED: 10/30/2006
Proterra AG Plaintiff	Gregory B. Sephton (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Nicholas Nicholas Kallas (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Robert Louis Baechtold (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED David M Conca (See above for address) TERMINATED: 10/30/2006
Dr. Reddy's Laboratories, Ltd. Defendant	Maurice Newmark Ross Budd Larner P.C. 11 Penn Plaza 50th Floor NY, NY 10001 (973) 315-4526 Fax: (973) 379-7734 Email: mross@bartonesq.com ATTORNEY TO BE NOTICED
Dr. Reddy's Laboratories, Inc. Defendant	Maurice Newmark Ross (See above for address) ATTORNEY TO BE NOTICED
Dr. Reddy's Laboratories, Inc. Counter Claimant	Maurice Newmark Ross (See above for address) ATTORNEY TO BE NOTICED
Dr. Reddy's Laboratories, Ltd. Counter Claimant	Maurice Newmark Ross (See above for address) ATTORNEY TO BE NOTICED
Novartis International Pharmaceutical Ltd. Counter Defendant	David M Conca (See above for address) TERMINATED: 10/30/2006
Novartis Pharma AG Counter Defendant	David M Conca (See above for address) TERMINATED: 10/30/2006
Novartis Pharmaceuticals Corporation Counter Defendant	David M Conca (See above for address) TERMINATED: 10/30/2006
Proterra AG Counter Defendant	David M Conca (See above for address) TERMINATED: 10/30/2006
Dr. Reddy's Laboratories, Inc. Counter Claimant
Novartis Pharmaceuticals Corporation Counter Defendant
Novartis AG Counter Defendant	David M Conca (See above for address) TERMINATED: 10/30/2006
Novartis Pharma AG Counter Defendant
Novartis International Pharmaceutical Ltd. Counter Defendant
Proterra AG Counter Defendant
Dr. Reddy's Laboratories, Ltd. Counter Claimant
Dr. Reddy's Laboratories, Inc. Counter Claimant
Dr. Reddy's Laboratories, Ltd. Counter Defendant
Dr. Reddy's Laboratories, Inc. Counter Defendant
Dr. Reddy's Laboratories, Ltd. Counter Claimant
Dr. Reddy's Laboratories, Inc. Counter Claimant
Novartis Pharma AG Counter Defendant
Novartis International Pharmaceutical Ltd. Counter Defendant
Proterra AG Counter Defendant
Novartis Pharmaceuticals Corporation Counter Defendant
Novartis AG Counter Defendant

Documents

Date Filed	Document #	Attachment #	Short Description	Long Description	Upload date	SHA1 hash
2004-08-04	1	0		COMPLAINT against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. (Filing Fee $ 150.00, Receipt Number 515921)Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG.(jjm, ) Additional attachment(s) added on 8/6/2004 (jjm, ). (Entered: 08/05/2004)
2004-08-04	2	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Novartis International Pharmaceutical Ltd. (jjm, ) Additional attachment(s) added on 8/6/2004 (jjm, ). (Entered: 08/05/2004)
2004-08-04	3	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Proterra AG.(jjm, ) Additional attachment(s) added on 8/6/2004 (jjm, ). (Entered: 08/05/2004)
2004-08-04	4	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Novartis Pharma AG.(jjm, ) Additional attachment(s) added on 8/6/2004 (jjm, ). (Entered: 08/05/2004)
2004-08-04	5	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Novartis Pharmaceuticals Corporation.(jjm, ) Additional attachment(s) added on 8/6/2004 (jjm, ). (Entered: 08/05/2004)
2004-08-04	6	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Novartis AG.(jjm, ) Additional attachment(s) added on 8/6/2004 (jjm, ). (Entered: 08/05/2004)
2004-09-07	7	0		WAIVER OF SERVICE RETURNED EXECUTED Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. Dr. Reddy's Laboratories, Inc. waiver sent on 8/13/2004, answer due 10/12/2004. (Prugo, Filko) (Entered: 09/07/2004)
2004-09-07	8	0		WAIVER OF SERVICE RETURNED EXECUTED Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. Dr. Reddy's Laboratories, Ltd. waiver sent on 8/13/2004, answer due 10/12/2004. (Prugo, Filko) (Entered: 09/07/2004)
2004-10-01	9	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Ross, Maurice) (Entered: 10/01/2004)
2004-10-01	10	0		ANSWER to Complaint., COUNTERCLAIM against Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. Document filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Ross, Maurice) (Entered: 10/01/2004)	2010-11-08 16:08:53	944876572cfce0fafddbf0fe0f3cbcc650da44d5
2004-10-05	11	0		CASE MANAGEMENT PLAN: Amend the pleadings by 1/3/2005. Joinder of additional parties by 11/17/2004. All discovery to be expeditiously completed by 3/10/2005 (Fact and Expert). Status of settlement discussions 3/18/05 at 9:00 a.m. with most senior principals present in Court. (Signed by Judge Richard M. Berman on 10/5/04) (yv, ) (Entered: 10/06/2004)
2004-10-07	12	0		ORDER REFERRING CASE TO MAGISTRATE JUDGE. Order that case be referred to the Clerk of Court for assignment to a Magistrate Judge for General Pretrial. Referred to Magistrate Judge James C. Francis. (Signed by Judge Richard M. Berman on 10/7/04) (yv, ) (Entered: 10/07/2004)
2004-10-15	13	0		ORDER REFERRING CASE to Mediation...referring action to the Clerk to assign the above-entitled action to mediation.All issues are eligible for mediation. (Signed by Judge Richard M. Berman on 10/12/04) (djc, ) (Entered: 10/19/2004)
2004-10-20	14	0		AMENDED ANSWER to., COUNTERCLAIM against all plaintiffs. Document filed by Dr. Reddy's Laboratories, Inc.. (Ross, Maurice) (Entered: 10/20/2004)
2004-10-13	15	0		ORDER REFERRING CASE TO MAGISTRATE JUDGE. Order that case be referred to the Clerk of Court for assignment to a Magistrate Judge for General Pretrial. Referred to Magistrate Judge James C. Francis. (Signed by Judge Richard M. Berman on 10/7/04) (yv, ) (Entered: 10/21/2004)
2004-11-01	16	0		MOTION to Consolidate Cases 04c 5477 (N.D. IL.); 04cv07594 (C.D. CA) Novartis Pharmaceuticals Corp. et al. v. Sun Pharmaceutical Industries, Ltd; Novartis Pharmaceuticals Corp. et al. v. Watson Pharmaceuticals Inc, et al.. Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. (Conca, David) (Entered: 11/01/2004)
2004-11-01	17	0		MEMORANDUM OF LAW in Support re: 16 MOTION to Consolidate Cases 04c 5477 (N.D. IL.); 04cv07594 (C.D. CA) Novartis Pharmaceuticals Corp. et al. v. Sun Pharmaceutical Industries, Ltd; Novartis Pharmaceuticals Corp. et al. v. Watson Pharmaceuticals Inc, et al... Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. (Conca, David) (Entered: 11/01/2004)
2004-11-01	18	0		CERTIFICATE OF SERVICE of Motion for Consolidation, Memorandum in Support of Motion for Consolidation, Corporate Disclosure Statement, and Conca Declaration in Support of Motion for Consolidation served on Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. on 11/01/2004. Service was made by Mail. Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. (Conca, David) (Entered: 11/01/2004)
2004-11-01	19	0		RULE 7.1 DISCLOSURE STATEMENT. Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG.(Conca, David) (Entered: 11/01/2004)
2004-11-03	20	0		DECLARATION of David M. Conca in Support re: 16 MOTION to Consolidate Cases 04c 5477 (N.D. IL.); 04cv07594 (C.D. CA) Novartis Pharmaceuticals Corp. et al. v. Sun Pharmaceutical Industries, Ltd; Novartis Pharmaceuticals Corp. et al. v. Watson Pharmaceuticals Inc, et al... Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. (Attachments: # 1 Exhibit 1-5# 2 Exhibit 6# 3 Exhibit 7-13# 4 Exhibit 14-21)(Conca, David) (Entered: 11/03/2004)
2004-11-08	21	0		REPLY re: 14 Amended Answer to Complaints, Counterclaim. Document filed by Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG. (Conca, David) (Entered: 11/08/2004)	2010-11-08 21:02:09	bfe50a45cbdd9233637e62a7b644410277a16f91
2004-11-10	22	0		ORDER. By 12/1/2004, counsel shall submit any motions or letter briefs regarding any disputes concerning responses to document demands. Also by 12/1/04, counsel shall report on the status of discussions concerning (a) consolidation of the related cases in this Court by stipulation and without the need for motion practice before the Multidistrict Litigation Panel, (b) formal coordination of discovery among the related cases, and (c) proposed revisions to the case management order. Pending entry of a comprehensive confidentiality order, the parties shall exchange documents subject to review by outside counsel only. The prior order assigning this case to the Court's mediation program is vacated. The next pretrial conference is scheduled for 12/14/2004 at 09:30 AM. Counsel shall submit any letters identifying disputed issues to be discussed at the conference no later than 12/10/04 and may submit any reply letters by 12/13/04 (Signed by Judge James C. Francis on 11/10/04) Copies mailed by Chambers.(yv, ) (Entered: 11/11/2004)
2004-12-02	23	0		ENDORSED LETTER addressed to Judge Francis from Diego Scambia dated 11/29/04 re: request that the due date for motions or letter briefs regarding any disputes concerning responses to document demands be extended to 12/8/04. Application granted. (Signed by Judge James C. Francis on 12/1/04) (yv, ) (Entered: 12/02/2004)
2004-12-21	27	0		ORDER. By 1/5/05, counsel shall submit a proposed joint scheduling order or, if no agreement is reached, proposed alternative scheduling orders. Novartis shall serve and file its motion to amend the complaint by 1/12/2005. Defendants shall answer the motion by 1/26/05, and Novartis shall reply by 2/2/2005. Novartis shall answer each of the interrogatories propounded by Reddy, including subparts. The complexity of this case justifies exceeding the 25-interrogatory limit, and the information sought concerning the identity of witnesses is important to conducting discovery efficiently. Contention interrogatories may be served at the close of fact discovery, and counsel are urged to agree on an appropriate limit on the number of such interrogatories. Absent agreement by the parties or a court order dealing with specific documents, the parties shall use the date of the filing of the complaint as the presumptive cut-off date for documents to be produced (Signed by Judge James C. Francis on 12/21/04) Copies mailed by Chambers.(yv, ) (Entered: 12/22/2004)
2005-01-07	28	0		STIPULATION AND ORDER regarding procedures to be followed that shall govern the handling of "confidential materials". (Signed by Judge James C. Francis on 1/6/05) (jco, ) (Entered: 01/10/2005)
2005-01-07	29	0		ORDER requests for production of documents, interrogatories and requests to admit are subject to the terms of the Consolidation Stipulation between the parties, and can be served on or after 12/17/04; Joinder of additional parties must be accomplished by 2/4/05. Document production shall be completed by 3/15/05. Any additional amended pleadings must be filed by 3/24/05; Fact depositions can begin no earlier than 4/1/05. All fact discovery must be completed by 7/1/05. Opening expert reports for which a party bears the burden of proof shall be served on 7/15/05. Expert discovery 10/14/05; Dispositive motions 12/15/05; response 1/16/06; reply 1/31/06. The pretrial order shall be filed 30 days after final decision of any dispositive motion. So Ordered. (Signed by Judge James C. Francis on 1/7/05) (jco, ) (Entered: 01/10/2005)
2005-01-07	30	0		ORDER. Requests for production of documents, interrogatories and requests to admit are subject to the terms of the consolidation stipulation between the parties, and can be served on or after 12/17/04. Joinder of additional parties must be accomplished by 2/4/2005. Document production shall be completed by 3/15/05. Any additional amended pleadings must be filed by 3/24/2005. Fact depositions can begin no earlier than 4/1/05. All fact discovery must be completed by 7/1/2005. Opening expert reports for which a party bears the burden of proof shall be served on 7/15/05. Rebuttal expert reports shall be served on 8/15/05. Reply expert reports shall be served on 9/1/05. Depositions on expert reports shall occur from 9/2/05 to 10/14/05. Absent agreement of the parties otherwise, each expert deposition shall presumptively be limited to one full day. Expert discovery shall be completed by 10/14/05. Dispositive motions, if any, shall be served 12/15/05. Answering papers shall be served 1/16/06. Reply papers shall be served 1/31/06. The pretrial order shall be filed 30 days after final decision of any dispositive motion (Signed by Judge James C. Francis on 1/7/05) Copies mailed by Chambers.(yv, ) (Entered: 01/11/2005)
2005-01-10	31	0		ORDER ADMITTING ATTORNEY PRO HAC VICE. Attorney James F. Hurst for defendant Sun Pharmaceutical Industries, Ltd., Kristen G. Cowan for defendant Sun Pharmaceutical Industries, Ltd. admitted Pro Hac Vice, subject to payment of fee to Clerk. (Signed by Judge Richard M. Berman on 1/10/05) (yv, ) Modified on 1/12/2005 (yv, ). (Entered: 01/12/2005)
2005-01-12	32	0		MOTION to Amend/Correct 1 Complaint, and to Amend Complaints against Watson Pharmaceuticals Inc., et al., and Sun Pharmaceutical Industries, Ltd.. Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. (Conca, David) (Entered: 01/12/2005)
2005-01-12	33	0		MEMORANDUM OF LAW in Support re: 32 MOTION to Amend/Correct 1 Complaint, and to Amend Complaints against Watson Pharmaceuticals Inc., et al., and Sun Pharmaceutical Industries, Ltd... Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. (Conca, David) (Entered: 01/12/2005)
2005-01-12	34	0		DECLARATION of Simon A. Fitzpatrick in Support re: 32 MOTION to Amend/Correct 1 Complaint, and to Amend Complaints against Watson Pharmaceuticals Inc., et al., and Sun Pharmaceutical Industries, Ltd... Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A - C# 2 Exhibit D - F# 3 Exhibit G - I# 4 Exhibit J -L)(Conca, David) (Entered: 01/12/2005)
2005-01-12	35	0		CERTIFICATE OF SERVICE of Notice of Motion to Amend the Complaints, Memorandum of Law in Support of Motion to Amend the Complaints, and Declaration of Simon Fitzpatrick in Support of Motion to Amend the Complaints served on Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Watson Pharmaceuticals, Inc., Watson Laboratories, Inc., and Sun Pharmaceutical Industries, Ltd. on 1/12/05. Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. (Conca, David) (Entered: 01/12/2005)
2005-01-26	36	0		RESPONSE in Opposition re: 32 MOTION to Amend/Correct 1 Complaint, and to Amend Complaints against Watson Pharmaceuticals Inc., et al., and Sun Pharmaceutical Industries, Ltd... Document filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Affidavit Lars Taavola# 2 Exhibit 1-2# 3 Exhibit 3# 4 Exhibit 4# 5 Exhibit 5-6# 6 Exhibit 7-11# 7 Exhibit 12-13# 8 Exhibit 14-15# 9 Exhibit 16# 10 Certificate of Service)(Ross, Maurice) (Entered: 01/26/2005)
2005-02-02	37	0		REPLY MEMORANDUM OF LAW in Support re: 32 MOTION to Amend/Correct 1 Complaint, and to Amend Complaints against Watson Pharmaceuticals Inc., et al., and Sun Pharmaceutical Industries, Ltd... Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Certificate of Service)(Conca, David) (Entered: 02/02/2005)
	37	1	Certificate of Service
2005-02-18	38	0		NOTICE OF CASE REASSIGNMENT to Judge Harold Baer. Judge Richard M. Berman no longer assigned to the case. (gf, ) (Entered: 02/24/2005)
2005-02-18	39	0		CERTIFIED TRUE COPY OF CONDITIONAL MDL TRANSFER IN ORDER FROM THE MDL PANEL... that pursuant to 28 U.S.C. 1407, the action(s) listed... and pending... be, and the same hereby are... with consent of that court, assigned to the Honorable Harold Baer, for coordinated or consolidated pretrial proceedings with the actions pending in that district... (Signed by Judge MDL Panel on 2/16/05) (gf, ) (Entered: 03/08/2005)
2005-03-22	40	0		ORDER ISSUING LETTER ROGATORY that the Clerk of Courts shall issue the letter rogatory in the form attached to this order. So Ordered. (Signed by Judge James C. Francis on 3/22/05) (jco, ) (Entered: 03/24/2005)
2005-04-25	41	0		MEMORANDUM AND ORDER (this document relates to 04cv6045, 05cv2234, 05cv2235); that for the reasons set forth in this Order, Novartis' motion to amend their complaints is granted. (Signed by Magistrate Judge James C. Francis on 4/25/2005) Copies Mailed by Chambers. Filed In Associated Cases: 1:05-md-01661-HB,1:04-cv-06045-HB, 1:05-cv-2234-HB, 1:05-cv-2235-HB(kkc, ) (Entered: 04/26/2005)
2005-05-10	42	0		CASE MANAGEMENT ORDER NO. 1 (this document relates to all actions); 1. All attorneys who have been admitted to this Court, either for all purposes or pro hac vice for purposes of this case, shall complete and file a CM/ECF attorney registration form. Forms can be found on the court's website at www.nysd.uscourts.gov.2. All attorneys who wish to be admitted for purposes of this case shall send a motion to be admitted pro hac vice to John Sacco at the United States District Court for the Southern District of New York, 500 Pearl Street, Room 249, New York, NY 10007. In addition to the documentation required by the Local Rules for the Southern and Eastern Districts of New York, Civil Rule 1.3, attorneys wishing to appear pro hac vice must also include with their motion a check for $25.00 payable to the Clerk of the Court and a completed CM/ECF attorney registration form. 3. As of May 9, 2005, all documents filed in the MDL case and the underlying civil cases shall be filed electronically on the court's ECF system via the Internet at ecf.nysd.uscourts.gov4. Amended complaints and supplemental pleadings shall provide a list of the additional parties and indicate the action or actions to which they are being added. Similarly, a filing removing parties shall indicate the parties being removed and the action or actions from which they are being removed. A filing which adds a party or parties who has not been named in any of the consolidated actions shall provide a separate listing of such parties, indicating that they have not yet been named. (Signed by Magistrate Judge James C. Francis on 5/9/2005) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-03160-HB(kkc, ) (Entered: 05/10/2005)
2005-05-10	43	0		AMENDED COMPLAINT amending 1 Complaint, against Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. Related document: 1 Complaint, filed by Novartis AG,, Novartis Pharmaceuticals Corporation,, Novartis Pharma AG,, Novartis International Pharmaceutical Ltd.,, Proterra AG,.(kw, ) (Entered: 05/11/2005)
2005-05-12	44	0		AMENDED COMPLAINT amending 1 Complaint, against Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG. Related document: 1 Complaint, filed by Novartis AG,, Novartis Pharmaceuticals Corporation,, Novartis Pharma AG,, Novartis International Pharmaceutical Ltd.,, Proterra AG,.(pl, ) (Entered: 05/13/2005)
2005-05-12	45	0		CERTIFICATE OF SERVICE of Summons and Amended Complaint,. Dr. Reddy's Laboratories, Ltd. served on 5/5/2005, answer due 5/25/2005; Dr. Reddy's Laboratories, Inc. served on 5/5/2005, answer due 5/25/2005. Service was accepted by Maurice Ross, Esq.. Document filed by Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; Proterra AG; Novartis Pharmaceuticals Corporation; Novartis AG. (pl, ) (Entered: 05/13/2005)
2005-05-16	46	0		CERTIFICATE OF SERVICE of Amended Answer and Counterclaims served on Novartis Pharmaceuticals Corp, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceuticals, Proterra AG on May 12, 2005. Service was made by Mail. Document filed by Dr. Reddy's Laboratories, Inc.. Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF(Ross, Maurice) (Entered: 05/16/2005)
2005-05-18	47	0		AMENDED ANSWER to., COUNTERCLAIM against all defendants. Document filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Ross, Maurice) (Entered: 05/18/2005)
2005-05-19	48	0		AMENDED ANSWER to., COUNTERCLAIM against all plaintiffs. Document filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Ross, Maurice) (Entered: 05/19/2005)
2005-05-31	49	0		ANSWER to Counterclaim. Document filed by Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Proterra AG, Novartis AG. (Attachments: # 1 Certificate of Service)(Conca, David) (Entered: 05/31/2005)
2005-07-27	50	0		ORDER; that the Clerk of the Court is instructed to close the aforementioned "open motion" because it was resolved. (Signed by Judge Harold Baer on 7/25/05) (pl, ) (Entered: 07/28/2005)
2005-11-21	51	0		EXCIPIENT SAMPLE STIPULATION AND ORDER that Reddy agrees that in each of the rivastigmine capsule products that are the subject of its ANDA, the excipients will not in any way affect testing results concerning the amount of (S)-N-ethyl-N-methyl-3-(1-(dimethylamino)ethyl)-phenyl carbamate present in those products... and as further set forth in said order. (Signed by Judge James C. Francis on 11/21/05) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF(rjm, ) (Entered: 11/23/2005)
2006-02-27	52	0		STIPULATION AND ORDER that the collective "Plaintiffs" and "Sun" through their respective counsel, and in order to narrow the issues of pretrial discovery and trial and to conserve judicial resources, stipulate as follows: Sun stipulates it infringes claims 1, 2, and 3 of the '176 patent, should the Court find these claims valid and enforceable. Sun reserves all challenges to the validity and enforceability of the claims of the '176 patent. This stipulation is no admission of liability and is made to simplify this litigation. Plaintiffs stipulate & agree to forgo taking the depositions of Messrs. Shivramchandra, Doshi, and Rajamannar, subject to there being a substantial need to take those depositions in light of the production of any additional documents. Sun stipulates that Messrs. Doshi, Shivramchandra and Rajamannar will not appear as witnesses at trial or otherwise, unless their depositions are taken... and as further set forth in said stipulation & order. (Signed by Judge James C. Francis on 2/24/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, ) (Entered: 02/28/2006)
2006-05-31	53	0		STIPULATION AND ORDER. It is hereby stipulated and agreed, between Novartis and DRL, through their undersigned attorneys, that This DRL Action is stayed in its entirety; DRL stipulates that if the '807 patent is held enforceable, and either claim 3 or 4 of the '807 patent is held valid, the valid claim(s) would be infringed by its rivastigmine tartrate ANDA product, and that if the '176 patent is held enforceable, and any claims 1, 2, 3 or 5 of the '176 patent is held valid, the valid claims would be infringed by its rivastigmine tartrate ANDA product... and as further set forth in said stipulation and order. (Signed by Judge James C. Francis on 5/31/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF(rjm, ) (Entered: 05/31/2006)
2006-08-31	56	0		STIPULATION AND ORDER regarding the procedures to be followed that shall govern the handling of Privileged Documents. This Document relates to All Actions. (Signed by Judge James C. Francis on 8/31/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, ) (Entered: 08/31/2006)
2006-10-30	57	0		ORDER: It is hereby ordered that David M. Conca be permitted to withdraw as counsel in this action and the Clerk is directed to note such withdrawal. (Signed by Judge Harold Baer on 10/26/2006) (lb, ) (Entered: 10/30/2006)
2006-11-27	58	0		STIPULATION AND ORDER... regarding the schedule that shall govern the remainder of the proceedings in this Court... and as further set forth in said stipulation and order. (Signed by Judge James C. Francis on 11/22/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, ) (Entered: 11/27/2006)
2007-01-03	59	0		STIPULATION AND ORDER... It is hereby stipulated and agreed by and between the undersigned counsel for Plaintiffs and Defendants that the following schedule shall govern the remainder of the proceedings in this Court. Expert Depositions due by 7/27/2007. Fact Discovery due by 2/9/2007. Dispositive Motions due by 11/2/2007. Replies to Dispositive Motions due by 12/14/2007. Responses to dispositive motions due by 11/30/2007. Service to Responses to Contention Interrogatories due 2/23/07. Identification of opening experts on which parties will rely for opening expert reports due 3/2/07. Submission of opening expert reports due 3/23/07. Production/identification of expert documents relating to opening expert reports due 3/30/07. Submission of rebuttal expert reports due 5/4/07. Production/identification of expert documents relating to rebuttal expert reports due 5/25/07. Submission of reply expert reports due 5/25/07. Production/identification of expert documents relating to reply expert reports due 6/1/07. Close of expert discovery due 7/27/07. Simultaneous exchange of list of proposed meanings of claim terms requiring construction due 8/10/07. Simultaneous Submission of Opening briefs concerning claim construction due 9/7/07. Simultaneous Submission of Response briefs concerning claim construction due 10/5/07. (Signed by Judge James C. Francis on 12/28/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, ) (Entered: 01/04/2007)
2007-04-30	60	0		REPLY MEMORANDUM OF LAW in Support MOTION FOR LEAVE TO FILE AN AMENDED ANSWER AND COUNTERCLAIMS. Document filed by Watson Pharmaceuticals Inc., Watson Laboratories Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc.. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:04-cv-06045-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB, 1:05-cv-07820-HB(Stronski, James) (Entered: 04/30/2007)
2007-09-19	61	0		DECLARATION of Dr. Jay Ellis in Support of Plaintiffs' Opening Brief in Support of Their Proposed Construction of U.S. Patent 4,948,807. Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG, Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp., Novartis International Pharmaceutical, Ltd., Novartis Pharmaceuticals. (Attachments: # 1 Exhibit 1-2# 2 Exhibit 3-5)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:04-cv-06045-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB, 1:05-cv-07820-HB(Kallas, Nicholas) (Entered: 09/19/2007)
2008-01-18	62	0		NOTICE of of Stipulation of Dismissal. Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Novartis Pharmaceuticals Corporation, Novartis AG. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:04-cv-06045-HB-JCF(Kallas, Nicholas) (Entered: 01/18/2008)
2008-02-29	63	0		MINUTE ORDER PURSUANT TO MEMORANDUM FROM THE ADMINISTRATIVE OFFICE OF THE U.S. COURTS, DATED JUNE 15TH, 1973....Case Closed administratively pursuant to Memorandum from the Administrative Office of the United States Courts dated June 15th, 1973.... (Signed by Judge Kimba M. Wood on 2/29/08) (cd) (Entered: 03/06/2008)